FFR research - key publications using PLN antibodies

Please rate these pages to support our infographic project:
Get free premium widgets for your blog and website.

  1. Hagemann, D. et al. 2000. Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J Biol Chem. 275(29), pp.22532-6.
  2. Huke, S. and Bers, D.M. 2007. Temporal dissociation of frequency-dependent acceleration of relaxation and protein phosphorylation by CaMKII. J Mol Cell Cardiol. 42(3), pp.590-9.
  3. Isoda, T. et al. 2003. Novel regulation of cardiac force-frequency relation by CREM (cAMP response element modulator). Faseb Journal. 17(2), pp.144-151.
  4. Munch, G. et al. 2000. SERCA2a activity correlates with the force-frequency relationship in human myocardium. American Journal of Physiology-Heart and Circulatory Physiology. 278(6), pp.H1924-H1932.
  5. Valverde, C.A. et al. 2005. Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation. J Physiol. 562(Pt 3), pp.801-13.
  6. Zhao, W. et al. 2004. Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility. Journal of Molecular and Cellular Cardiology. 37(2), pp.607-612.

Back to main infographic.

About us
meet the team
Badrilla is a manufacturer of outstanding antibodies against cardiac proteins and phospho-proteins, and the manufacturer of leading kits for the study of protein S-palmitoylation.

Follow us on social

Contact us
We look forward to providing your favourite antibodies and kits
gender and body